The Viral Antigens market was valued at US$101.41 million in 2019 and is projected to reach US$ 236.80 million by 2027; it is expected to grow at a CAGR of 11.0% during 2020–2027.
A virus can infect all types of life forms, from plants and animals to archaea and bacteria. A viral antigen is a poison or toxic substance administered by these virulent entities, which induces immune reaction in its host. For instance, a viral antigen is determined by IFA in neutrophils and platelets from bone marrow or blood or in serum, saliva, tears, or plasma by ELISA. Nucleic amplification tests can also be used to determine the stage of infection. The best outcomes are obtained when antigens are measured through blood tests or serum
A virus can infect all types of life forms, from plants and animals to archaea and bacteria. A virus antigen is a poison or toxic substance administered by a virus that induces an immune reaction in its host. A viral protein is an antigen identified by the viral genome that can be recognized through a particular immunological response. A viral antigen is determined by IFA in neutrophils and platelets from bone marrow or blood or in serum, saliva, tears, or plasma by ELISA. Nucleic amplification tests can also be used to determine the stage of infection. The best outcomes are obtained when antigens are measured through blood tests or serum.
Lucrative Regions in Viral Antigens Market
Get more information on this report :
Market Insights
Increased Acceptance of Viral Antigens in Vaccine Development Fuels Market Growth
A viral antigen is a toxin or other substance released by a virus that is capable of inducing an immune response (to create an antibody) in the host organism. A viral protein is a viral genome-specified antigen that can be recognized by a specific immunological response. Vaccination aims to establish immunity in the host that, in the event of an infectious pathogen, will prevent illness. Therefore, in its simplest form, vaccine development for viral diseases involves the distribution of antigens that induce virus-specific neutralizing antibodies and avoid the induction of any off-target antibodies.
The development and use of vaccines has greatly reduced the number of illnesses and diseases over the years. The introduction of a variety of new types of vaccines has been made possible through the manipulation of DNA, RNA, proteins and sugars, increased knowledge of immune response, and a major leap in genetic engineering. Development of attenuated mutants, expression of possible antigens in live vectors, and purification and direct synthesis of antigens in new systems have significantly enhanced the vaccine technology.
Products Insights
In terms of component, the Coronavirus antigens segment held the largest share of the viral antigens market in 2019, and is expected to continue its dominance and register a higher the highest CAGR in the market during the forecast period.
Viral Antigens Market, by Component – 2019 and 2027
Get more information on this report :
Application Insights
Based on end user, the global viral antigens market is segmented into hospitals, clinics, laboratories, diagnostic centers, blood banks, and research institutes. The diagnostic centers segment held the largest share of the market in 2019, and the market for laboratories is expected to register grow at the highest CAGR during the forecast period.
A laboratory is a place where clinical specimen tests are conducted to collect information on the patient's health to help diagnose, treat, and prevent disease. Over the last few decades, there has been a significant revolution in viral diagnostic laboratories' services and their role in patients' clinical management. Laboratories differ in size and sophistication, providing a wide range of research facilities. More extensive services may be seen in Aacute care hospitals and medical centers might provide extensive services, where and 70% of clinical decisions are based on laboratory tests. Doctoral offices and clinics, and specialist nursing and long-term care facilities can have laboratories that offer more basic testing services. Accurate diagnosis of the virus requires laboratory examination of clinical specimens for the presence of viral antigens, viruses, or specific antibodies. Over the last few decades, there has been a significant revolution in viral diagnostic laboratories' service and their role in patients' clinical management.
Strategic Insights
Report Coverage - Viral Antigens Market
Report Coverage
Details
Market Size Value in
US$ 101.41 Million in 2019
Market Size Value by
US$ 236.80 Million by 2027
Growth rate
CAGR of 11.0% from 2020-2027
Forecast Period
2020-2027
Base Year
2020
No. of Pages
200
No. of Tables
87
No. of Charts & Figures
86
Historical data available
Yes
Segments covered
Component Antigens ; Technique ; and End User ; and Geography
Regional scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country scope
US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
Report coverage
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Free Sample Copy Available
Players operating in the viral antigens market adopt collaboration and partnership strategies to meet demands of end users through the introduction of technologically advanced offerings, and these strategies significantly support the growth of the market.
A virus can infect all types of life forms, from plants and animals to archaea and bacteria. A virus antigen is a poison or toxic substance administered by a virus that induces an immune reaction in its host. A viral protein is an antigen identified by the viral genome that can be recognized through a particular immunological response. A viral antigen is determined by IFA in neutrophils and platelets from bone marrow or blood or in serum, saliva, tears, or plasma by ELISA. Nucleic amplification tests can also be used to determine the stage of infection. The best outcomes are obtained when antigens are measured through blood tests or serum.
The global viral antigens market is being driven by factors such increased acceptance of viral antigens in vaccine development and advancements in image analysis software and informatics platforms for viral antigen detection. Furthermore, emerging markets is likely to offer significant opportunities for the growth of the global viral antigens market.
The high cost of vaccine development is the significant factor that will hinder the viral antigens market growth.
The List of Companies - Viral Antigens Market
Microbix Biosystems
BIO-RAD LABORATORIES INC.
Creative Diagnostics
Aalto Bio Reagents Ltd.
Advanced Biotechnologies Inc.
Prospec-Tany Technogene Ltd.
ACROBiosystems.
MERIDIAN BIOSCIENCE, INC.
Rekom Biotech S.L
LGC Limited
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the viral antigens market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global viral antigens market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.